切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (05) : 505 -509. doi: 10.11817/j.issn.1673-9248.2023.05.014

综述

透析患者脑小血管病患病情况的研究现状及其机制探讨
白明悦, 杨淑娜, 胡红梅, 胡文立()   
  1. 100020 首都医科大学附属北京朝阳医院神经内科
  • 收稿日期:2023-05-22 出版日期:2023-10-01
  • 通信作者: 胡文立
  • 基金资助:
    国家自然科学基金项目(82001244)

Research status and mechanism exploration on the prevalence of cerebrovascular disease in dialysis patients

Mingyue Bai, Shuna Yang, Hongmei Hu, Wenli Hu()   

  1. Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
  • Received:2023-05-22 Published:2023-10-01
  • Corresponding author: Wenli Hu
引用本文:

白明悦, 杨淑娜, 胡红梅, 胡文立. 透析患者脑小血管病患病情况的研究现状及其机制探讨[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 505-509.

Mingyue Bai, Shuna Yang, Hongmei Hu, Wenli Hu. Research status and mechanism exploration on the prevalence of cerebrovascular disease in dialysis patients[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 505-509.

脑小血管病(CSVD)是导致老年人认知障碍、步态异常、情感障碍和日常生活能力下降的重要原因之一。目前研究发现接受持续性透析治疗的终末期肾病患者的CSVD、认知障碍、情感障碍的发生率远高于健康人群。本综述查阅近5年相关文献,阐述透析患者CSVD研究现状,并试图探讨其发病机制,以期广大研究者和临床医师关注和重视透析患者CSVD的发病情况及其所导致的临床症状。

Cerebrovascular disease (CSVD) is one of the important causes of cognitive impairment, gait abnormalities, emotional disorders, and decreased daily living ability in elderly people. At present, it has been found that the incidence of CSVD, cognitive impairment, and emotional disorders in end-stage renal disease patients receiving continuous dialysis treatment is much higher than that of healthy individuals. This review reviews relevant literature in the past 5 years, elaborates on the current research status of CSVD in dialysis patients, and attempts to explore its pathogenesis, to attract attention from researchers and clinical physicians to the incidence and clinical symptoms of CSVD in dialysis patients.

1
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990 - 2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. Lancet, 2020, 395(10225): 709 - 733.
2
Sun Q, Zheng J, Zhang Y, et al. Altered spontaneous brain activities in maintenance hemodialysis patients with cognitive impairment and the construction of cognitive function prediction models [J]. Ren Fail, 2023, 45(1): 2217276.
3
Chatrenet A, Piccoli G, Audebrand JM, et al. Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease [J]. J Cachexia Sarcopenia Muscle, 2023.
4
Zhu L, Li XL, Shi R, et al. Dialysis vintage is associated with a high prevalence and severity of unpleasant symptoms in patients on hemodialysis [J]. Ren Fail, 2023, 45(1): 2201361.
5
Wang Y, Shi C, Li Y, et al. Genetic study of cerebral small vessel disease in Chinese Han population [J]. Front Neurol, 2022, 13: 829438.
6
Markus HS, de Leeuw FE. Cerebral small vessel disease: recent advances and future directions [J]. Int J Stroke, 2023, 18(1): 4-14.
7
van den Brink H, Doubal FN, Duering M. Advanced MRI in cerebral small vessel disease [J]. Int J Stroke, 2023, 18(1): 28-35.
8
中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021 [J]. 中国卒中杂志, 2021, 16(7): 716-726.
9
Naganuma T, Takemoto Y. Asymptomatic cerebrovascular disease in dialysis patients [J]. Contrib Nephrol, 2018, 196: 22-26.
10
钱玉珺, 杨建萍, 侯波, 等. 维持性血液透析与腹膜透析患者认知功能障碍的比较[J]. 中华肾脏病杂志,2020, 36(9):657-665.
11
Qian Y, Zheng K, Wang H, et al. Cerebral microbleeds and their influence on cognitive impairment in dialysis patients [J]. Brain Imaging Behav, 2021, 15(1): 85-95.
12
Lau WL, Nunes ACF, Vasilevko V, et al. Chronic kidney disease increases cerebral microbleeds in mouse and man [J]. Transl Stroke Res, 2020, 11(1): 122-134.
13
Chai C, Wang Z, Fan L, et al. Increased number and distribution of cerebral microbleeds is a risk factor for cognitive dysfunction in hemodialysis patients: a longitudinal study [J]. Medicine (Baltimore), 2016, 95(12): e2974.
14
Naganuma T, Kabata D, Takemoto Y, et al. Antiplatelet therapy and future intracerebral hemorrhage in hemodialysis patients with cerebral microbleeds [J]. J Clin Neurosci, 2021, 90: 155-160.
15
单艳棋, 相丽, 邹立巍, 等. 中青年终末期肾脏病腹膜透析患者脑白质损伤与认知功能改变的相关性研究[J]. 中国医学影像技术, 2016, 32(10):5.
16
Zhang R, Liu K, Yang L, et al. Reduced white matter integrity and cognitive deficits in maintenance hemodialysis ESRD patients: a diffusion-tensor study [J]. Eur Radiol, 2015, 25(3): 661-668.
17
Richerson WT, Umfleet LG, Schmit BD, et al. Changes in cerebral volume and white matter integrity in adults on hemodialysis and relationship to cognitive function [J]. Nephron, 2021, 145(1): 35-43.
18
Chen X, Huang L, Ye Q, et al. Disrupted functional and structural connectivity within default mode network contribute to WMH-related cognitive impairment [J]. Neuroimage Clin, 2019, 24: 102088.
19
Mu J, Ma L, Ma S, et al. Neurological effects of hemodialysis on white matter microstructure in end-stage renal disease [J]. Neuroimage Clin, 2021, 31: 102743.
20
Naganuma T, Takemoto Y, Shoji T, et al. Cerebral white matter hyperintensity predicts cardiovascular events in haemodialysis patients [J]. Nephrology (Carlton), 2013, 18(10): 676-681.
21
田晓琳. 维持性血液透析的ESRD患者的认知障碍及其与脑小血管病的关系 [D]. 天津: 天津医科大学, 2019.
22
石艳, 童朝阳, 张明昊, 等. 无认知损害维持性血液透析患者的脑部病变——来自MRI的证据 [J]. 重庆医科大学学报, 2019, 44(9): 5.
23
Zheng K, Zhou Y, Qian Y, et al. Increased premature cerebral small vessel diseases in dialysis patients: a retrospective cross-sectional study [J]. Nephron, 2021, 145(4): 330-341.
24
Reeves PB, Mc Causland FR. Mechanisms, clinical implications, and treatment of intradialytic hypotension [J]. Clin J Am Soc Nephrol, 2018, 13(8): 1297-1303.
25
郑可, 侯波, 有慧, 等. 维持性血液透析患者的脑部损害 [J]. 中华肾脏病杂志, 2015, 31(4): 277-282.
26
Cao MX, Xiao J, Qin HM, et al. Dialysis adequacy and hemoglobin levels predict cerebral atrophy in maintenance-hemodialysis patients [J]. J Cereb Blood Flow Metab, 2023, 43(6): 882-892.
27
Yu H, Zhang C, Cai Y, et al. Morphological brain alterations in dialysis- and non-dialysis-dependent patients with chronic kidney disease [J]. Metab Brain Dis, 2023, 38(4): 1311-1321.
28
Tsuruya K, Yoshida H. Brain atrophy and cognitive impairment in chronic kidney disease [J].Contrib Nephrol, 2018, 196: 27-36.
29
Cohen-Hagai K, Fanadka F, Grumberg T, et al. Diastolic blood pressure is associated with brain atrophy in hemodialysis patients: a single center case-control study [J]. Ther Apher Dial, 2022, 26(1): 94-102.
30
Chai C, Zhang M, Long M, et al. Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis [J]. Metab Brain Dis, 2015, 30(4): 1009-1016.
31
Mizumasa T, Hirakata H, Yoshimitsu T, et al. Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: a 3-year prospective study [J]. Nephron Clin Pract, 2004, 97(1): c23-c30.
32
万慧婷, 邢昌赢. 血液透析患者血管钙化的诊治进展 [J]. 中国实用内科杂志, 2021, 41(11): 922-925922-925, 930.
33
Jiang XL, Wen JQ, Zhang LJ, et al. Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging [J]. Metab Brain Dis, 2016, 31(4): 929-936.
34
Anazodo UC, Wong DY, Théberge J, et al. Hemodialysis-related acute brain injury demonstrated by application of intradialytic magnetic resonance imaging and spectroscopy [J]. J Am Soc Nephrol, 2023, 34(6): 1090-1104.
35
韩雪, 王昊, 王丽妍, 等. 维持性血液透析患者脑小血管病患病影响因素分析 [J]. 临床和实验医学杂志, 2022, 21(11): 1163-1166.
36
Roy-Chaudhury P, Tumlin JA, Koplan BA, et al. Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle [J]. Kidney Int, 2018, 93(4): 941-951.
37
Canney M, Sood MM, Hundemer GL. Reducing the risk of atrial fibrillation in ESKD: is the devil in the dialysis? [J]. Nephrol Dial Transplant, 2021, 36(11): 1963-1964.
38
Canaud B. Recent advances in dialysis membranes [J]. Curr Opin Nephrol Hypertens, 2021, 30(6): 613-622.
39
Yeter HH, Korucu B, Akcay OF, et al. Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis [J]. Int Urol Nephrol, 2020, 52(9): 1779-1789
40
Brophy DF, Carl DE, Mohammed BM, et al. Differences in coagulation between hemodialysis and peritoneal dialysis [J]. Perit Dial Int, 2014, 34(1): 33-40.
41
Gameiro J, Jorge S, Lopes JA. Haemodialysis-related-heparin-induced thrombocytopenia: Case series and literature review [J]. Nefrologia (Engl Ed), 2018, 38(5): 551-557.
42
陈道军, 詹锋, 武伟, 等. 腹膜透析导管植入术后患者凝血功能的改变 [J]. 实用医学杂志, 2012, 28(17): 2.
43
李艺, 丁国华. 腹膜透析患者凝血功能状态及其影响因素分析 [J]. 中国血液净化, 2021, 20(1): 5.
44
Xia W, Kuang M, Li C, et al. Prognostic significance of the albumin to fibrinogen ratio in peritoneal dialysis patients [J]. Front Med (Lausanne), 2022, 9: 820281.
45
Yu J, Lin T, Huang N, et al. Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study [J]. BMC Nephrol, 2020, 21(1): 349.
46
Zhang Y, Yi J, Zhang R, et al. Risk factors for arteriovenous fistula thrombus development: a systematic review and meta-analysis [J]. Kidney Blood Press Res, 2022, 47(11):643-653.
47
Forsberg U, Jonsson P, Stegmayr C, et al. Microemboli, developed during haemodialysis, pass the lung barrier and may cause ischaemic lesions in organs such as the brain [J]. Nephrol Dial Transplant, 2010, 25(8): 2691-2695.
48
Toth-Manikowski SM, Sozio SM. Cooling dialysate during in-center hemodialysis: Beneficial and deleterious effects [J]. World J Nephrol, 2016, 5(2): 166-171.
49
Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter [J]. J Am Soc Nephrol, 2015, 26(4): 957-965.
50
Álvarez Nadal M, Martín Capón I, Viera Ramírez ER, et al. Absolute blood volume variations during hemodialysis: does dialysate temperature play a role? [J]. Semin Dial, 2021, 34(4): 309-314.
51
Dasgupta I, Odudu A, Baharani J, et al. Evaluation of the effect of cooled haemodialysis on cognitive function in patients suffering with end-stage kidney disease (E-CHECKED): feasibility randomised control trial protocol [J]. Trials, 2020, 21(1): 820.
52
Ertuglu LA, Demiray A, Basile C, et al. Sodium and ultrafiltration profiling in hemodialysis: a long-forgotten issue revisited [J]. Hemodial Int, 2021, 25(4): 433-446.
53
Vareesangthip K, Davenport A. Reducing the risk of intradialytic hypotension by altering the composition of the dialysate [J]. Hemodial Int, 2020, 24(3): 276-281.
[1] 杨静, 顾红叶, 赵莹莹, 孙梦霞, 查园园, 王琪. 老年血液透析患者短期死亡的影响因素及列线图预测模型的预测作用[J]. 中华肾病研究电子杂志, 2023, 12(05): 254-259.
[2] 杨聚荣. 透析患者妊娠的管理[J]. 中华肾病研究电子杂志, 2023, 12(05): 300-300.
[3] 罗阳燕, 王少清, 高芳, 沈艳, 张万军, 李莉. 尿毒清颗粒对腹膜透析患者残余肾功能及腹透液纤连蛋白和TGF-β1水平的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 200-204.
[4] 陈客宏. 干细胞外泌体防治腹膜透析腹膜纤维化新技术研究[J]. 中华肾病研究电子杂志, 2023, 12(03): 180-180.
[5] 樊佩琦, 闫燕, 李晓霞, 武玲宇, 郭罡玲, 李静, 王利华. 2020年山西省腹膜透析患者贫血的流行病学调查及相关因素分析[J]. 中华肾病研究电子杂志, 2023, 12(03): 121-126.
[6] 于梦园, 杨立明, 朱学研, 张晓暄, 刘声茂, 谢舜昀, 倪册, 庄小花, 崔文鹏. 肠源性腹膜透析相关性腹膜炎治疗失败的危险因素:多中心回顾性研究[J]. 中华肾病研究电子杂志, 2023, 12(03): 127-133.
[7] 王珊, 马清, 姚兰, 杨华昱. 老年维持性血透患者叶酸治疗与miR-150-5p血清水平的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(03): 139-144.
[8] 常文轩, 王婷, 刘伟, 蓝天琦, 彭静, 汪诗瑶, 张晓鹏, 冯晨, 宫雪梅, 朱敏. 脑小血管病所致执行障碍的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 179-182.
[9] 周加军, 余永武, 周涵, 张凌. 358例继发性甲状旁腺功能亢进症患者异位甲状旁腺的检出及分布情况分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 381-385.
[10] 张赟辉, 罗军, 刘栗丽, 汪宏, 耿克明. 腹膜透析与血液透析对老年终末期肾病患者营养状况及炎症反应的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 419-423.
[11] 张天, 余京华, 王攀登, 郭晨凡, 刘涛. 一例使用异物抓捕器治疗导管纤维蛋白鞘的病例报告[J]. 中华介入放射学电子杂志, 2023, 11(03): 284-286.
[12] 晏美娟, 邵礼晖. 高水平脂蛋白(a)与无“三高”老年人群小动脉硬化型脑小血管病的相关性研究[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 458-463.
[13] 丁文华, 王育伟, 邱景景, 杨琼, 耿玉荣. 脑小血管病影像学标志物与运动障碍研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 429-434.
[14] 王道合, 施媛媛. 8-iso-PGF2α及P选择素在评估脑小血管病患者认知功能中的价值[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 364-368.
[15] 刘琳, 张奇山, 廖蔓倩, 陈余榕, 李倍, 何玉成, 唐圣桃. HTRA1相关常染色体显性脑小血管病家系报告并文献复习[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 379-385.
阅读次数
全文


摘要